Pathstone Holdings LLC Boosts Stock Position in Morgan Stanley (NYSE:MS)

Pathstone Holdings LLC boosted its holdings in shares of Morgan Stanley (NYSE:MS) by 3.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 168,843 shares of the financial services provider’s stock after purchasing an additional 5,367 shares during the quarter. Pathstone Holdings LLC’s holdings in Morgan Stanley were worth $17,600,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Rosenberg Matthew Hamilton lifted its holdings in shares of Morgan Stanley by 2.6% in the 3rd quarter. Rosenberg Matthew Hamilton now owns 3,748 shares of the financial services provider’s stock valued at $391,000 after acquiring an additional 96 shares during the last quarter. Omnia Family Wealth LLC boosted its holdings in shares of Morgan Stanley by 3.3% in the 3rd quarter. Omnia Family Wealth LLC now owns 3,063 shares of the financial services provider’s stock worth $319,000 after purchasing an additional 97 shares during the period. TFB Advisors LLC increased its position in shares of Morgan Stanley by 3.9% during the 3rd quarter. TFB Advisors LLC now owns 2,662 shares of the financial services provider’s stock valued at $277,000 after purchasing an additional 99 shares during the last quarter. Compagnie Lombard Odier SCmA raised its holdings in Morgan Stanley by 0.3% during the 3rd quarter. Compagnie Lombard Odier SCmA now owns 33,850 shares of the financial services provider’s stock valued at $3,529,000 after buying an additional 100 shares during the period. Finally, Lansing Street Advisors lifted its position in Morgan Stanley by 0.8% in the third quarter. Lansing Street Advisors now owns 12,284 shares of the financial services provider’s stock worth $1,280,000 after buying an additional 103 shares during the last quarter. Institutional investors own 84.19% of the company’s stock.

Insider Buying and Selling at Morgan Stanley

In other Morgan Stanley news, Director Stephen J. Luczo sold 60,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $119.17, for a total value of $7,150,200.00. Following the completion of the sale, the director now directly owns 138,363 shares in the company, valued at $16,488,718.71. This trade represents a 30.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.24% of the stock is owned by insiders.

Morgan Stanley Trading Down 1.2 %

NYSE:MS opened at $132.21 on Wednesday. The firm has a 50-day simple moving average of $113.97 and a 200-day simple moving average of $104.49. Morgan Stanley has a one year low of $76.33 and a one year high of $135.51. The firm has a market cap of $213.00 billion, a P/E ratio of 20.12, a P/E/G ratio of 1.25 and a beta of 1.34. The company has a debt-to-equity ratio of 3.14, a quick ratio of 0.80 and a current ratio of 0.80.

Morgan Stanley (NYSE:MS) last issued its quarterly earnings data on Wednesday, October 16th. The financial services provider reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.31. The company had revenue of $15.38 billion during the quarter, compared to the consensus estimate of $14.27 billion. Morgan Stanley had a net margin of 10.64% and a return on equity of 12.58%. Equities analysts anticipate that Morgan Stanley will post 7.32 EPS for the current fiscal year.

Morgan Stanley Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Thursday, October 31st were given a dividend of $0.925 per share. This represents a $3.70 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date was Thursday, October 31st. Morgan Stanley’s payout ratio is currently 56.32%.

Analyst Ratings Changes

MS has been the topic of a number of analyst reports. Royal Bank of Canada boosted their price objective on shares of Morgan Stanley from $108.00 to $122.00 and gave the company a “sector perform” rating in a research report on Thursday, October 17th. UBS Group increased their price objective on shares of Morgan Stanley from $102.00 to $112.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 8th. HSBC upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $118.00 target price for the company in a research report on Friday, October 4th. Barclays increased their price target on Morgan Stanley from $121.00 to $135.00 and gave the stock an “overweight” rating in a report on Thursday, October 17th. Finally, The Goldman Sachs Group boosted their price objective on Morgan Stanley from $106.00 to $121.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Eleven equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $111.29.

About Morgan Stanley

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.